Tag Archives: neutrophils

Atlas, Novartis Put $27M Into IFM to Battle Cancer, Autoimmune Diseases

There is no shortage of companies out there trying to tweak our immune systems in one way or another to treat diseases like cancer. Today, IFM Therapeutics, a new startup seeded by Boston firm Atlas Venture, has joined the fray. IFM, a startup in Cambridge, MA, disclosed a $27 million Series A round led by […]

Posted in Boston, Boston blog main, Boston top stories, Detroit blog main, Detroit top stories, National blog main, New York blog main, New York top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Atlas, Novartis Put $27M Into IFM to Battle Cancer, Autoimmune Diseases

With New Execs, Sanofi Backing, ImmuneXcite Begins Clinical Push

It’s not unusual for the team that founds a biotech startup to hand the reins to someone else once it’s time to take the next step. That’s where ImmuneXcite is, now that the Lexington, MA-based startup has gotten the support of some big-name investors. The VC arm of Sanofi (Sanofi-Genzyme BioVentures), Cormorant Asset Management, and […]

Posted in Boston, Boston blog main, National blog main, National top stories, New York blog main, New York top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on With New Execs, Sanofi Backing, ImmuneXcite Begins Clinical Push

East Coast Biotech Roundup: Forum, Crossovers, Immuno-Oncology & More

It was marathon Monday this week in Boston, but East Coast biotech executives were running around all week. There was a big cancer meeting in Philadelphia, a neurology shindig in Washington DC, and a liver conference that just kicked off in Europe. And the usual spate of financings and deals for a bunch of local […]

Posted in Boston, Boston blog main, Boston top stories, National blog main, New York blog main, New York top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on East Coast Biotech Roundup: Forum, Crossovers, Immuno-Oncology & More

ImmuneXcite Enlists Body’s First Defender for Immune Attack on Cancer

Immuno-oncology is all the rage these days, and it’s easy to see why. Breakthroughs in harnessing the power of our body’s natural defenses are unlocking new ways to fight cancer, and producing some of the most promising results the field has seen to date. But it’s not as if someone has magically cracked the code […]

Posted in Boston, Boston blog main, National blog main, New York blog main, New York top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on ImmuneXcite Enlists Body’s First Defender for Immune Attack on Cancer